Regal-backed 'lab on a stick' biotech Nexsen launches IPO
Nexsen, a biotech developing rapid pregnancy diagnostics for GBS, has kicked off an IPO aiming for ASX listing by end of September; Regal is named as an earlier backer.
Investor · 1 deal
Every published round Regal took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Buildxact | Series A | 1 Feb 2022 | $18.5m | Lead | Shearwater Capital, Startup Daily (7 Feb 2022), Startup Daily (2 Feb 2022), iTnews, buildxact.com, Shearwater Capital portfolio |
Companies Regal has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Buildxact | 1 Feb 2022, Series A | 1 | 1 |
Fund closes reported for Regal, as distinct from the investments it has made.
Companies Regal has backed that another company then bought. An exit for the holding, not a deal Regal did.
Stories naming Regal. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Nexsen, a biotech developing rapid pregnancy diagnostics for GBS, has kicked off an IPO aiming for ASX listing by end of September; Regal is named as an earlier backer.
Share trading platform Superhero is demerging from crypto exchange Swyftx, its founders resuming control via a management buyout backed by earlier investors, as Swyftx contends with crypto downturn and repeated staff cuts.
Ignition Lane's weekly tech roundup: AirTree raises $700m across three new funds, dozens of Australian startups announce rounds, a wave of acquisitions including Block completing its Afterpay buy, plus Web3 commentary and US market moves.
Also SmartCompany·SmartCompany·SmartCompany·Startup Daily·Startup Daily·SmartCompany·Startup Daily
AFR healthcare and fitness section roundup: Early Bird raised $2 million led by Hyper Ventures; Resmed sold MatrixCare; Radiopharm seeks $16 million; plus Mayne Pharma, Healthscope, Sigma and policy stories.
Also SmartCompany